Identification of rare cell types in lung cancer and investigation of their use in prognosis

Yıldız, Cemal
Şengül Babal, Simge
Pir, Pınar
Cancer is a complex, dynamic and heterogeneous disease. Identification of tumor heterogeneity holds a significant promise not only on tumor classification but also on predicting the prognosis and choosing the right treatment. Therefore, it is essential to investigate tumor heterogeneity in a regular diagnosis procedure. Tumors contain variety of cell types such as malignant cells, non-malignant cells, immune cells, and rare cells (i.e., dormant cells (DRM) and cancer stem cells (CSC)). [1] All these cell types contribute to the disease progression. For example, dormant cells are major cause of recurrence of cancer because they disseminate from the tumors and enter into a state of cellular dormancy (G0/G1 arrest), and they may start dividing again after a prolonged period of dormancy. [2]The arrival of single cell RNA sequencing (scRNAseq) provides new opportunities for exploring gene expression profile at the single-cell level. scRNA technique has become favorable for studying the heterogeneous diseases such as cancer. [3]In this study, rare cell types from single-cell RNA sequencing data [1]were identified by using the Seurat tool[4]in R programing language and single-cell references were determined to analyze bulk data. Bulk data from TCGA[5]were analyzed to find cell type proportions by using the MuSiC tool [6]and survival models were generated to discover whether these rare cell types contribute to the survival time and if they can be used for prognosis. DRM cells negatively affect survival probability of LUADand LUSC patients over time. These results may indicate that cells in dormant state cannot be detected and eliminated in any treatment applied, and that the disease relapses after a while


Detection of rare cell types and patient prognosis in liver cancer
Şengül Babal, Simge; Yıldız, Cemal; Pır, Pınar (Orta Doğu Teknik Üniversitesi Enformatik Enstitüsü; 2022-10)
Cancer is a disease that emerges as a result of complex aberrant processes involving cells that grow and divide uncontrollably and has many patient-specific characteristics. Mutations in genes or changes in the expression of transcripts produce cellular heterogeneity, cancer cells, and tumors, and finally invade other healthy tissues [1]. Primary liver cancer is the second most lethal malignancy worldwide and comprises many molecularly unique subtypes and a highly diverse microenvironment [2]. Among this di...
Identification of gene mutations involved in drug resistance in liver cancer using RNA-SEQ data analysis
Shojaei, Mona; Atalay, Rengül; Acar, Aybar Can; Department of Bioinformatics (2016)
A significant concern in cancer research is the detection of cancer associated somatic mutations. Liver cancer is the 5th most common and 2nd deadliest cancer in the world. Several somatic mutations were previously reported in liver cancer but their relations to chemotherapeutic response was not studied in detail. In this study, the relationship between mutation status and drug treatment response of well-differentiated Huh7 and poorly-differentiated Mahlavu liver cancer cells were analyzed. The RNA-Seq data...
Effects of novel compound derived from vitamin e on prostate cancer cell line
Ergen, Nuri; Severcan, Feride; Department of Biology (2016)
Cancer is a complex disease characterized by uncontrolled cell proliferation, invasion and metastasis. It is known that vitamins having high antioxidant capacity, like vitamin A, C and E, play important roles in adjuvant therapy and as cancer protective agents. Vitamin E is a group of fat soluble antioxidant nutrients consisting of tocopherols and tocotrienols. Various research has been performed on the utility of vitamin E derivatives on cancer treatment. Energy metabolism of cells alters during cancer pro...
Microarray applications for determination of the effects of emodin on breast cancer cell lines
Ekenel Qomi, Emilia; İşcan, Mesude; Çoruh, Nursen; Department of Biotechnology (2011)
Cancer is a genetic disease that is characterized by uncontrolled cells growth. Breast cancer is a type of cancer originating from breast tissue. Some breast cancers are sensitive to hormones such as estrogen which makes it possible to treat them by blocking the effects of these hormones in the target tissues. These require less aggressive treatment than hormone negative cancers. Breast cancers without hormone receptors, are higher-risk, and are treated more aggressively. The aim of our study is to investig...
Synthesis of poly (dl-lactic-co-glycolic acid) coated magnetic nanoparticles for anti-cancer drug delivery
Tansık, Gülistan; Gündüz, Ufuk; Department of Biology (2012)
One of the main problems of current cancer chemotherapy is the lack of selectivity of anti-cancer drugs to tumor cells which leads to systemic toxicity and adverse side effects. In order to overcome these limitations, researches on controlled drug delivery systems have gained much attention. Nanoscale based drug delivery systems provide tumor targeting. Among many types of nanocarriers, superparamagnetic nanoparticles with their biocompatible polymer coatings can be targeted to an intented site by an extern...
Citation Formats
C. Yıldız, S. Şengül Babal, and P. Pir, “Identification of rare cell types in lung cancer and investigation of their use in prognosis,” Erdemli, Mersin, TÜRKİYE, 2022, p. 3013, Accessed: 00, 2023. [Online]. Available: